Welcome
Support Centre
18 March 2010 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The influence of moderate alcohol consumption on insulin sensitivity
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN51658532
Date ISRCTN assigned23/01/2004
Local reference number(s)RS/06/07.98/Fl
Public titleThe influence of moderate alcohol consumption on insulin sensitivity
Scientific title
AcronymN/A
Disease/condition/study domainCardiovascular diseases: Heart disease
Study hypothesisThe consumption of modest amounts of alcohol, on a regular basis, appears to reduce the risk of developing cardiovascular disease. The aim of this study was to determine whether alcohol exhibits this protection through a reduction in insulin resistance.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaNot provided at time of registration
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/02/1999
Anticipated end date31/01/2000
Status of trialCompleted
Target number of participantsNot provided at time of registration
Interventions1. 3 units of alcohol in the form of vodka daily for 7 days
2. No alcohol
Primary outcome measure(s)Fasting glucose, insulin, insulin sensitivity or glucose effectiveness, first phase insulin secretion
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingNHS Executive South West
Sponsor nameNHS R&D Regional Programme Register - Department of Health (UK)
Sponsor detailsThe Department of Health
Richmond House
79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44 (0)20 7307 2623
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.doh.gov.uk
Contact nameDr Daniel Flanagan
Contact detailsRoyal Bournemouth & Christchurch NHS Trust
Bournemouth Diabetes and Endocrine Centre
Castle Lane East
Bournemouth
United Kingdom
BH7 7DW
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN51658532
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
terms & conditions | privacy statement | © Current Controlled Trials Ltd. Part of Springer Science+Business Media.


BioMed Central